title: First report of safety and efficacy of daratumumab in 2 cases of advanced immunoglobulin light chain amyloidosis.
authors.affiliation: Mayo Clinic, Jacksonville, FL.
authors.forename: Taimur
authors.initials: T
authors.lastname: Sher
authors.affiliation: Mayo Clinic, Jacksonville, FL.
authors.forename: Brooke
authors.initials: B
authors.lastname: Fenton
authors.affiliation: Florida Hospital, Orlando, FL; and.
authors.forename: Adnan
authors.initials: A
authors.lastname: Akhtar
authors.affiliation: Mayo Clinic, Jacksonville, FL; Mayo Clinic, Rochester, MN.
authors.forename: Morie A
authors.initials: MA
authors.lastname: Gertz
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D018450:Disease Progression; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000097:blood; D000075363:Immunoglobulin Light-chain Amyloidosis / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D007147:Immunoglobulin Light Chains; C556306:daratumumab